Pharmaceutical Companies Expand AI Use to Accelerate Drug Discovery

Major pharmaceutical companies are increasingly adopting artificial intelligence to speed up drug discovery and reduce research costs. Industry leaders report that AI-driven platforms are helping identify potential drug candidates faster, optimize clinical trial design, and improve success rates. Analysts say the growing use of AI could significantly shorten development timelines and reshape how new medicines reach patients worldwide.